-
Investigating the Mechanism of Jiawei Weijin Decoction in Treating Non-Small Cell Lung Cancer Using Network Pharmacology, Bioinformatics Analysis and Experimental Validation
25 Sep 2025 08:23 GMT
… cell lung cancer (NSCLC) cases among all lung cancer cases … the prevalent treatments of lung cancer mainly include surgery, … 47;). Subsequently, we employed AutoDock Tools to perform … 47;mTOR pathway in lung cancer; oncogenic alterations, therapeutic …
-
US Navy Veterans Lung Cancer Advocate Urges a Navy Veteran Nationwide Who Has Lung Cancer and Who Had Asbestos Exposure on a Ship-Submarine Before 1983 to Call About Compensation-Don't Play Lawyer Roulette
24 Sep 2025 09:45 GMT
… veterans who have developed lung cancer or mesothelioma because of … , we are not commissioned employees of a law firm, … compensation who has asbestos exposure lung cancer:
* The Navy Veteran or … Thomas
US Navy Veterans Lung Cancer Advocate
+1 866-714 …
-
<![CDATA[Employing Comprehensive Genomic Testing in the NSCLC Paradigm]]>
24 Sep 2025 17:03 GMT
Hatim Husain, MD, spoke with CancerNetwork® regarding the use of comprehensive genomic profiling, specifically for patients with non–small cell lung cancer (NSCLC). Husain, a professor in the Department of Medicine at the University of California San Diego …
-
MaineHealth Pen Bay and Waldo Hospitals to participate in National Lung Cancer Screening Day Nov. 8
23 Sep 2025 14:21 GMT
… for CT lung cancer screening appointments as part of National Lung Cancer Screening Day … in 10 eligible individuals undergo lung cancer screening.
“Lung cancer screening uses a special … . With more than 2,000 employed providers and approximately 23,000 …
-
<![CDATA[Developing a Patient-Centric Approach in Small Cell Lung Cancer Care]]>
23 Sep 2025 14:10 GMT
… with small cell lung cancer (SCLC) and other types of lung cancer, according to … of employing PROs in cancer management, especially among those with lung cancer. Being … options for our patients with lung cancer. Understanding which patients are having …
-
Ebp1 p48 Promotes Oncogenic Properties in Non-Small Cell Lung Cancer Through PI3K/Akt Signaling Pathways
22 Sep 2025 13:16 GMT
… prevalent pathological type of lung cancer. Current treatment strategies for … with non-small cell lung cancer was associated with … Kaplan–Meier analysis was employed. It was discovered that … in non‐small‐cell lung cancer via integrated bioinformatics analysis. …
-
Comparison of Postoperative Analgesic Effects of Intravenous versus Perineural Dexamethasone Injection Combined with Ropivacaine in Thoracoscopy-Guided Thoracic Paravertebral Block for Thoracoscopic Radical Lung Cancer Resection: A Prospective…
22 Sep 2025 07:13 GMT
… For early- and mid-stage lung tumors, surgical resection remains the … analysis, and the estimation method employed was restricted maximum likelihood ( … undergoing thoracoscopic radical resection for lung cancer commonly experience significant postoperative …
-
Interstitial Lung Disease Significantly Increases Risk of All Lung Cancer Types: Study
21 Sep 2025 14:58 GMT
… all major histological subtypes of lung cancer, including adenocarcinoma, squamous cell … sibling-controlled design was also employed, comparing affected individuals with ILD … ILD as a variable in lung cancer risk stratification algorithms.
Reference:
…
-
What research might be lost after the NIH’s cuts? Nature trained a bot to find out
25 Sep 2025 10:31 GMT
… account given by an ex-employee at the Department of Government … spending seen as excessive. The employee told investigative website ProPublica in … 2011 study3 that found that lung-cancer screening using low-dose computed …
-
Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μL
25 Sep 2025 08:23 GMT
… of asthma, cystic fibrosis, lung cancer, or interstitial lung disease, … Propensity score matching was employed to mitigate the risks of … Zeneca. LGSB was an employee of Optum at the time … . LGSB and BC are employees of Boehringer Ingelheim Pharmaceuticals, …